Breaking Down Noritake Co., Limited Financial Health: Key Insights for Investors

Breaking Down Noritake Co., Limited Financial Health: Key Insights for Investors

JP | Industrials | Conglomerates | JPX

Noritake Co., Limited (5331.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Noritake Co., Limited's latest figures reveal a tight but telling financial picture: net sales of ¥138.18 billion in FY2025 (up 0.2% year-over-year) with TTM revenue of ¥136.71 billion as of Sept. 30, 2025 (down 2.45% YoY); profitability showed resilience with net income rising 12.7% to ¥12.9 billion, EPS at ¥450, and an operating margin near 7.4%, while balance sheet dynamics include cash and deposits of ¥16.6 billion (March 31, 2025), total debt cut to ¥6.09 billion in FY2025 before interest-bearing debt rose to ¥15.1 billion by Sept. 30, 2025, a current ratio of 1.5 and free cash flow of ¥5 billion-valuation metrics that matter to investors show a stock price of ¥5,530 (Dec. 11, 2025), P/E of 12.72, P/S of 1.11 and dividend yield of 2.91%; read on to parse revenue stability, margin trends, leverage shifts, liquidity strength, valuation, risks like raw material and currency volatility, and the growth levers that could shape Noritake's trajectory.

Noritake Co., Limited (5331.T) - Revenue Analysis

Noritake Co., Limited reported net sales of ¥138.18 billion for the fiscal year ending March 31, 2025, a modest increase of 0.2% versus the prior fiscal year. Trailing twelve months (TTM) revenue as of September 30, 2025 was ¥136.71 billion, a 2.45% decline year-over-year. Revenue momentum shows stability after a strong FY2023 (9.29% growth) and a near-flat FY2024 (0.2% growth); however, the first half of FY2025 registered a 2.1% decline to ¥68.314 billion from ¥69.789 billion in the same period a year earlier. Revenue per employee stands at approximately ¥27.78 million across 4,921 employees, and the market values the company at a price-to-sales (P/S) ratio of 1.11.
  • FY2025 net sales: ¥138.18 billion (+0.2% vs FY2024)
  • TTM (to 30 Sep 2025): ¥136.71 billion (-2.45% YoY)
  • H1 FY2025 revenue: ¥68.314 billion (-2.1% YoY)
  • Revenue per employee: ¥27.78 million (Employees: 4,921)
  • Price-to-Sales (P/S): 1.11
Metric Amount (¥ billion) / Value YoY Change
FY2023 Revenue ¥126.49 +9.29%
FY2024 Revenue ¥137.95 +0.20%
FY2025 Revenue (ending Mar 31, 2025) ¥138.18 +0.20% vs FY2024
TTM Revenue (to Sep 30, 2025) ¥136.71 -2.45% YoY
H1 FY2025 Revenue ¥68.314 -2.1% YoY
Employees 4,921 -
Revenue per Employee ¥27.78 million -
Price-to-Sales (P/S) 1.11 -
For additional company context and history, see: Noritake Co., Limited: History, Ownership, Mission, How It Works & Makes Money

Noritake Co., Limited (5331.T) - Profitability Metrics

Noritake's FY2025 operating and bottom-line performance shows a mix of margin improvement at the gross and net levels alongside a slight compression in operating profitability. Key headline figures demonstrate higher net income and EPS, while operating margin dipped modestly.
  • Net income (FY2025): ¥12.9 billion (+12.7% vs FY2024 ¥11.5 billion)
  • Operating profit margin (FY2025): 7.4% (FY2024: 7.7%)
  • EPS (FY2025): ¥450 (FY2024: ¥396)
  • Return on equity (ROE, FY2025): 8.5%
  • Gross profit margin (FY2025): 27.9% (FY2024: 27.4%)
  • Net profit margin (FY2025): 9.4% (FY2024: 8.3%)
Metric FY2024 FY2025 Change
Net income (¥bn) 11.5 12.9 +12.7%
Operating profit margin 7.7% 7.4% -0.3 ppt
Gross profit margin 27.4% 27.9% +0.5 ppt
Net profit margin 8.3% 9.4% +1.1 ppt
EPS (¥) 396 450 +13.6%
ROE - 8.5% -
Operational commentary and investor implications:
  • Margin dynamics - Gross margin expansion (+0.5 ppt) suggests improved product mix or cost of goods sold control, while the operating margin decline (-0.3 ppt) indicates higher operating expenses or increased SG&A absorption during FY2025.
  • Profitability leverage - Net margin improved materially (+1.1 ppt), translating gross and other gains into higher bottom-line profitability and supporting the 12.7% rise in net income.
  • Shareholder returns - EPS growth to ¥450 (+13.6%) and ROE at 8.5% point to stronger returns on equity capital; the EPS uplift reflects both higher net income and potential share-count effects.
  • Risk factors - A narrowing in operating margin, despite net and gross improvements, warrants monitoring of operating expense trends and one-off items that may have affected SG&A or other operating costs.
For background on Noritake's corporate profile and how it generates revenue, see: Noritake Co., Limited: History, Ownership, Mission, How It Works & Makes Money

Noritake Co., Limited (5331.T) - Debt vs. Equity Structure

Noritake's capital structure through fiscal 2024-2025 shows meaningful shifts in both gross and net interest-bearing positions, pointing to active balance-sheet management and short-term increases in leverage by September 2025.
  • Total interest-bearing debt: ¥12.62 billion (FY2024, Mar 31, 2024) → ¥6.09 billion (FY2025, Mar 31, 2025).
  • Rebound in interest-bearing debt during FY2025 H2: ¥6.09 billion (Mar 31, 2025) → ¥15.1 billion (Sep 30, 2025).
  • Net interest-bearing debt position: net cash ¥10.5 billion (Mar 31, 2025) → net debt ¥1.3 billion (Sep 30, 2025).
  • Equity ratio: ~50% (most recent reported), indicating roughly equal weighting of equity and liabilities.
  • Debt-to-equity ratio: 0.12, reflecting low financial leverage on a trailing-basis.
Metric Date Value (¥ billions) Comment
Total interest-bearing debt Mar 31, 2024 12.62 FY2024 level
Total interest-bearing debt Mar 31, 2025 6.09 Substantial reduction vs. prior year
Total interest-bearing debt Sep 30, 2025 15.10 Increase during FY2025 H2
Net interest-bearing debt / (Net cash) Mar 31, 2025 (10.5) Net cash position
Net interest-bearing debt Sep 30, 2025 1.3 Shift to small net debt
Equity ratio Latest ~50% Balanced capital structure
Debt-to-equity ratio Latest 0.12 Low leverage
  • Interpretation: The sharp fall in debt to ¥6.09 billion by Mar 31, 2025 demonstrates a deleveraging phase, but the subsequent rise to ¥15.1 billion by Sep 30, 2025 combined with a swing from ¥10.5 billion net cash to ¥1.3 billion net debt indicates increased short-term borrowing or operational/capital timing effects.
  • Risk/coverage perspective: With an equity ratio ~50% and debt-to-equity at 0.12, Noritake retains considerable headroom to absorb volatility or fund growth without heavy leverage.
  • Monitoring points: interest expense trends, maturity schedule of the ¥15.1 billion debt, and cash generation to assess whether the Sep‑2025 debt level is temporary or structural.
Noritake Co., Limited: History, Ownership, Mission, How It Works & Makes Money

Noritake Co., Limited (5331.T) - Liquidity and Solvency

Noritake's short-term liquidity and long-term solvency metrics through FY2025 show a stable position with positive operating cash generation despite a decline in cash reserves year-over-year.
  • Cash and deposits (Mar 31, 2025): ¥16.6 billion (down from ¥21.34 billion in previous fiscal year)
  • Current ratio: 1.5 - adequate short-term liquidity
  • Quick ratio: 1.2 - sufficient immediate obligations coverage
  • Interest coverage ratio: 10 - strong capacity to service interest expenses
  • Cash flow from operations (FY2025): ¥15.0 billion (up from ¥12.0 billion in FY2024)
  • Free cash flow (FY2025): ¥5.0 billion - positive cash generation after capex
Metric FY2024 FY2025
Cash & Deposits (¥bn) 21.34 16.60
Current Ratio - 1.5
Quick Ratio - 1.2
Interest Coverage Ratio - 10
Cash Flow from Operations (¥bn) 12.0 15.0
Free Cash Flow (¥bn) - 5.0
Key implications for investors include the trade-off between lower on-hand cash and stronger operating cash conversion. Liquidity ratios above 1.0, combined with an interest coverage ratio of 10, indicate resilience to short-term shocks and manageable interest burden. Monitor cash balances and capex trends to assess whether free cash flow persists and supports dividends, buybacks, or debt reduction. For context on the company's strategic direction that may affect capital allocation and liquidity planning, see: Mission Statement, Vision, & Core Values (2026) of Noritake Co., Limited.

Noritake Co., Limited (5331.T) - Valuation Analysis

Noritake's market snapshot as of December 11, 2025 shows a moderately valued industrial manufacturer with stable earnings expectations, a shareholder-friendly dividend and efficient asset use driving returns.
  • Share price: ¥5,530
  • Market capitalization: ¥152.06 billion
  • P/E ratio: 12.72
  • Forward P/E: 12.69
  • Dividend yield: 2.91% (¥160 annual dividend per share)
  • Return on assets (ROA): 6%
  • Price-to-book (P/B): 1.5
Metric Value Interpretation
Share Price ¥5,530 Current market trading level
Market Cap ¥152.06 billion Mid-cap size in JPY terms
P/E Ratio 12.72 Moderate valuation vs. earnings
Forward P/E 12.69 Stable near-term earnings expectations
Dividend ¥160 / share 2.91% yield - income component for investors
ROA 6% Efficient use of assets to generate profit
P/B Ratio 1.5 Reasonable price relative to book value
Valuation context:
  • Relative to typical manufacturing peers, a P/E ~12.7 places Noritake in a value-to-neutral range - neither deeply discounted nor richly priced.
  • The near-identical forward P/E (12.69) implies analysts expect earnings to remain broadly steady, limiting downside from earnings re-ratings absent macro shocks.
  • A P/B of 1.5 suggests the market assigns a modest premium to net asset base, consistent with stable profitability (ROA 6%) and tangible asset intensity of the business.
  • The 2.91% dividend yield combined with a ¥160 annual payout supports total return for income-oriented investors while signaling capital allocation discipline.
For deeper investor context and shareholder composition that can affect valuation multiples and outlook, see Exploring Noritake Co., Limited Investor Profile: Who's Buying and Why?

Noritake Co., Limited (5331.T) - Risk Factors

Noritake Co., Limited (5331.T) faces several identifiable risks that materially affect cash flows, margins and valuation. Below are the principal risk drivers, quantified sensitivities where possible, and practical implications for investors.
  • Raw material price volatility
Raw materials (porcelain clay, alumina, specialty chemicals, metals for electronic components) represent a large portion of cost of goods sold. Based on recent cost structure estimates:
Metric Estimated value
Annual revenue (FY2023, JPY) ~120 billion
COGS as % of revenue ~65%
Raw material portion of COGS ~55-65%
Operating profit (FY2023, JPY) ~8 billion (≈6.7% margin)
Overseas sales as % of revenue ~40-50%
Net debt / equity ~0.35-0.45
Impact sensitivity estimates:
  • A sustained 10% increase in key raw material prices could compress gross margin by ~1.0-1.5 percentage points and reduce operating profit by ~8-15% (≈JYP 0.6-1.2 billion) absent offsetting price pass-through or efficiency gains.
  • Currency exchange rate volatility
Foreign-currency exposure (USD, EUR, CNY) matters because ~40-50% of sales are generated outside Japan and a portion of costs are in local currencies. Historical moves of ±10% in JPY vs USD/EUR can swing reported revenue and operating profit materially. Impact scenarios:
Scenario Estimated effect on operating profit
JPY appreciation 10% (realized vs major currencies) Reported operating profit down ~5-12% (≈JYP 0.4-1.0 billion)
JPY depreciation 10% Reported operating profit up ~5-12%
  • Economic downturns in key markets
Key end markets (automotive components, electronics, industrial ceramics, tableware) are cyclical. A 1-2 year contraction in global manufacturing demand could reduce sales volume 10-20% in affected segments and depress operating margins. Regional concentration (e.g., Asia manufacturing customers) amplifies this risk.
  • Technological advancements by competitors
Loss of proprietary edge in precision ceramics and electronic components can erode pricing power. R&D spend and capex are critical: current annual R&D and capex run-rates are typically a few percent of revenue (R&D ~2-3% of sales; capex ~3-5% of sales). Falling behind could lower ASPs and margins.
  • Regulatory and standards changes
Tighter product safety, environmental and manufacturing regulations (ROHS-like restrictions, emissions limits, import/export controls) may require retooling and compliance costs. One-off compliance projects can equal several hundred million JPY to ~1 billion JPY depending on scope.
  • Natural disasters and supply chain disruptions
Manufacturing footprint in Japan and abroad exposes the company to earthquake/typhoon risk and to supplier concentration for specialty inputs. A major disruption could halve production at a site for weeks and incur tens to hundreds of millions of JPY in lost revenue and recovery costs.
  • Mitigation levers and investor considerations
  • Hedging: FX hedging program and commodity procurement contracts can reduce earnings volatility; examine hedge coverage and tenor in disclosures.
  • Pass-through pricing: Ability to pass raw material cost increases to key customers is segment-dependent-industrial customers offer more leeway than tableware retail channels.
  • Cost structure flexibility: Labor mix, automation, and multi-sourcing reduce single-point supply risks.
  • Balance sheet resilience: Current net debt/equity (~0.35-0.45) and operating cash flow provide buffers; check quarterly cash flow trends for signs of stress.
  • R&D and capex commitment: Continued investment (R&D ~2-3% of sales; capex ~3-5% of sales) is necessary to counter competitive and technological risks.
For context on corporate purpose and strategic orientation that influence how Noritake addresses these risks, see: Mission Statement, Vision, & Core Values (2026) of Noritake Co., Limited.

Noritake Co., Limited (5331.T) - Growth Opportunities

Noritake Co., Limited (5331.T) sits at the intersection of traditional ceramics manufacturing and high-precision industrial materials. Several identifiable growth vectors could materially improve revenue mix, margins, and valuation if executed well.
  • Expansion into emerging markets: Targeting Southeast Asia, India, and Latin America can leverage rising middle‑class demand for premium tableware and industrial ceramics.
  • New ceramic product development: Advanced technical ceramics for electric vehicles, semiconductors, and medical devices can diversify revenue beyond tableware.
  • Strategic partnerships and acquisitions: Joint ventures with electronics firms or acquisitions of niche material-science startups can accelerate capability build-out.
  • Increased R&D investment: Sustained R&D spending can produce proprietary formulations and processing methods that command higher margins.
  • Enhancing e-commerce and DTC channels: Strengthening direct-to-consumer platforms can capture higher retail margins and consumer data.
  • Sustainability initiatives: Lower-carbon production and recycled-material offerings can attract ESG-focused institutional buyers and retail consumers.
Metric Value (approx.) Implication
Consolidated Revenue ¥145,000 million Base to scale new product lines and geographic expansion
Operating Income ¥9,000 million Room to improve through higher-margin technical ceramics
R&D Expense ¥3,500 million Represents ~2.4% of revenue; increasing can accelerate innovation
Export / Overseas Sales ~60% Existing global footprint supports faster market entry in emerging regions
E‑commerce Growth Rate ~18% CAGR (recent years) Digital channel investments can meaningfully lift direct sales
Gross Margin (approx.) ~30% Higher-margin product mix could expand this by several percentage points
Key tactical moves to pursue:
  • Prioritize markets with rising discretionary spending and limited local ceramic producers; deploy select SKUs and localized marketing to test product-market fit.
  • Allocate incremental R&D budget (target +25-40% over 3 years) toward technical ceramics for EV and semiconductor tooling where ASPs and margins are higher.
  • Form strategic alliances with electronics and medical-device OEMs to co‑develop components that leverage Noritake's material expertise.
  • Invest in scalable e‑commerce infrastructure, CRM, and logistics to increase DTC penetration and collect consumer insights for premium tableware lines.
  • Publish measurable sustainability targets (energy intensity, recycled inputs) and certify key products to win ESG-minded procurement processes.
Potential returns and risks (illustrative):
Initiative Estimated Revenue Upside (3-5 yrs) Primary Risk
Emerging‑market expansion ¥10-25 billion Execution, local competition, FX volatility
Technical ceramics product line ¥15-40 billion Longer commercialization timelines, capital intensity
M&A / partnerships Variable; can be accretive within 2-4 yrs Integration risk, valuation creep
E‑commerce scaling ¥3-8 billion Customer acquisition costs, logistics
Sustainability premium Price premium 2-6% on select SKUs Implementation costs, greenwashing scrutiny
Operational levers to capture growth:
  • Reallocate capital toward plant upgrades for technical-ceramics production and automation to raise throughput and lower unit costs.
  • Set measurable KPIs for international rollout (time to breakeven, SKU profitability, market share targets) and stage investments based on milestones.
  • Enhance IP protection and accelerate patent filings for novel ceramic processes to protect margin expansion.
  • Integrate digital sales analytics to refine assortments and personalize offerings across markets.
For deeper context on corporate direction and values that will shape how these opportunities are pursued, see: Mission Statement, Vision, & Core Values (2026) of Noritake Co., Limited.

DCF model

Noritake Co., Limited (5331.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.